Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
SK Chemical to release first cell culture quadrivalent flu vaccine
By 황유미Published : Aug. 11, 2016 - 08:03
[THE INVESTOR] SK Chemical is releasing a flu vaccine, the first cell culture vaccine that covers four strains of influenza viruses, next month. A total of 5 million units have been manufactured, it announced on Aug. 10.
Dubbed SKY Cell Flu Quadrivalent, “it is a next generation vaccine that can prevent four kinds of viruses with a single vaccination,” the company said.
Dubbed SKY Cell Flu Quadrivalent, “it is a next generation vaccine that can prevent four kinds of viruses with a single vaccination,” the company said.
[
Multinational firm Glaxo Smith Kline already sells its own quadrivalent, that covers two influenza A strains (H1N1, H3N2) and two influenza B strains (Yamagata, Victoria).
SK Chemical’s vaccine, however, is the first to be manufactured by a cell culture method, which stabilizes and accelerates the manufacturing process, according to the company. It also is free from the possible allergic reactions to egg protein, as it uses aseptic culture medium instead of eggs used in traditional method.
By Hwang You-mee (glamazon@heraldcorp.com)
Multinational firm Glaxo Smith Kline already sells its own quadrivalent, that covers two influenza A strains (H1N1, H3N2) and two influenza B strains (Yamagata, Victoria).
SK Chemical’s vaccine, however, is the first to be manufactured by a cell culture method, which stabilizes and accelerates the manufacturing process, according to the company. It also is free from the possible allergic reactions to egg protein, as it uses aseptic culture medium instead of eggs used in traditional method.
By Hwang You-mee (glamazon@heraldcorp.com)
